Natália G. Sampaio, Tanja Davis, Linden J. Gearing, Antonio G. Dias Junior, Lise Chauveau, Georgie Wray-McCann, Valerie Odon, Vladyslava Liudkovska, Alexandra L. McAllan, Chiara Cursi, Alice Mayer, Madara Ratnadiwakara, Minna-Liisa Änkö, Maciej Cieśla, Paul J. Hertzog, Jan Rehwinkel
5 min
MDA5 is a well-known innate immune sensor that detects viral infection and triggers type I interferon responses. Despite its importance, the exact nature of the RNA molecules that activate MDA5 has remained controversial. This study aimed to identify the endogenous RNA ligands of MDA5 during infection with SARS-CoV-2 and encephalomyocarditis virus (EMCV) to clarify how this sensor distinguishes infected cells from healthy ones.
The researchers developed a high-stringency dual immunoprecipitation (IP) method combined with iCLIP (individual-nucleotide resolution crosslinking and immunoprecipitation) to isolate and sequence RNA molecules bound to endogenous MDA5 in live cells. They compared these findings across different cell types (THP1 and Calu-3) and viral infections. Additionally, they performed cytoplasmic RNA sequencing to analyze how viral infection alters host RNA processing and tested whether restoring RNA homeostasis by overexpressing the splicing factor SRSF3 could modulate MDA5 activation.
Contrary to the prevailing view that MDA5 primarily detects viral double-stranded RNA (dsRNA), the researchers found that MDA5 binds overwhelmingly to host-derived RNA during both EMCV and SARS-CoV-2 infections. These binding sites were frequently located in introns and near repetitive elements like Alu sequences. The study revealed that viral infection significantly disrupts host RNA processing, leading to an accumulation of aberrant, unspliced, or intron-containing transcripts in the cytoplasm. These aberrant host RNAs were enriched for MDA5 binding. Furthermore, the researchers showed that overexpressing the splicing factor SRSF3 reduced these aberrant transcripts and, consequently, blunted MDA5-mediated immune activation without inhibiting viral replication. This suggests that MDA5 acts as a guardian of RNA processing fidelity, detecting the cellular stress caused by viral interference with splicing.
This work shifts the paradigm of MDA5 sensing from direct pathogen-associated molecular pattern (PAMP) detection to an innate immune 'guarding' mechanism. By monitoring the integrity of host RNA processing, MDA5 can detect diverse viral infections that might otherwise shield their own RNA from sensors. This mechanism also provides a potential explanation for MDA5 activation in sterile inflammatory conditions and suggests that targeting RNA processing pathways could be a viable therapeutic strategy for modulating immune responses.
MDA5 is an innate immune RNA sensor that senses infection with a range of viruses and other pathogens. MDA5's RNA agonists are not well defined. Here we used single-nucleotide resolution crosslinking and immunoprecipitation (iCLIP) to study its ligands. Of note, upon infection with SARS-CoV-2 or encephalomyocarditis virus, MDA5 bound overwhelmingly to cellular RNAs. Many binding sites were intronic and proximal to Alu elements and to potentially base-paired structures. Concomitantly, cytoplasmic levels of aberrant transcripts and intron-containing unspliced transcripts increased in infected cells and displayed enrichment of MDA5 iCLIP peaks. Moreover, overexpression of the splicing factor SRSF3 reduced aberrant transcription and abrogated MDA5 activation. Taken together, we propose that MDA5 surveys RNA processing fidelity and can detect infections by sensing perturbations of post-transcriptional events such as splicing.
Alex: [deliberate] The authors' interpretation is that these repetitive elements provide the structural motifs — Poly(U) and Poly(A) tracts — that MDA5 filaments need to nucleate and assemble. So the virus creates the mess, and the host's own repetitive sequences provide the scaffold that triggers the alarm. It is an indirect but mechanistically coherent model.
Sam: [reflective] That is an unexpectedly elegant evolutionary arrangement. The virus forces the host to generate its own alarm signal. [[RP_SECTION:therapeutic-potential-and-constraints|Therapeutic potential and constraints]]
Alex: [measured] Which is also why the therapeutic angle is interesting. If the signal is host-derived RNA dysregulation rather than a viral PAMP, then you have a potential lever in RNA processing factors themselves. Stabilizing splicing fidelity — rather than targeting the virus directly — could modulate the innate immune response upstream of cytokine production.
Sam: [analytical] That has obvious relevance for pathologies like cytokine storm, where the immune response itself is the problem. But I want to push on the generalizability. What are the actual constraints on this model? [[RP_SECTION:experimental-scope-and-limitations|Experimental scope and limitations]]
Alex: [measured, acknowledging] Fair to flag. The study works primarily with THP1 and Calu-3 cell lines, and the viral challenge is limited to two pathogens. Whether this mechanism holds across a broader range of RNA viruses — and whether it operates similarly in primary tissue rather than immortalized lines — is genuinely open. The authors are careful about this, but it is the limitation that most constrains how far you can extend the claim.
Sam: [grounded] So the load-bearing finding is the causal link between splicing disruption and MDA5 activation, established through the SRSF3 rescue experiment. The iCLIP data on repetitive elements is strong supporting evidence for the mechanism, but the generalization to other pathogens and tissue contexts is still ahead of the data.
Alex: [precise] That is the right read. The core reframing — MDA5 as an inspector of host RNA integrity rather than a hunter of viral signatures — is well-supported within the experimental system. The scope of that reframing across immunology more broadly is the next question to answer.
Sam: [concluding] It is a meaningful shift in how we think about innate immune surveillance. Not intruder detection, but quality control — and the virus exploits the host's own machinery to generate the very signal that gives it away.
Alex: [measured, final] That is it for this look at the latest in innate immune research. Thanks for listening to ResearchPod.